Landmark survival analysis and impact of anatomic origin in prospective clinical trials of biliary tract cancer
Patients with gallbladder cancer have worse overall survival compared to those with other anatomic biliary tract cancer primary sites of origin and should be considered as a stratification factor in clinical trials. Landmark survival rates allow for adjusted prognosis prediction for patients with advanced biliary tract cancer who survive for some time.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Mair éad Geraldine McNamara, Andre Lopes, Harpreet Wasan, David Malka, David Goldstein, Jenny Shannon, Takuji Okusaka, Jennifer J. Knox, Anna Dorothea Wagner, Thierry André, David Cunningham, Markus Moehler, Lars Henrik Jensen, Dieter Koeberle, Tanios B Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Gallbladder Cancer | Gastroenterology | Nutrition